您的位置: 首页 > 农业专利 > 详情页

Compounds derived from diazepinona; Composition and Pharmaceutical Combination which comprises, useful for the treatment of a disorder or disease mediated by mGluR5 as Fragile X Syndrome, Parkinson's disease or reflux disease.
专利权人:
NOVARTIS AG
发明人:
BEHNKE DIRK,CARCACHE DAVID,ERTL PETER,KOLLER MANUEL,ORAIN DAVID
申请号:
CL2015000416
公开号:
CL2015000416A1
申请日:
2015.02.20
申请国别(地区):
CL
年份:
2015
代理人:
摘要:
The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.COMPUESTOS DERIVADOS DE DIAZEPINONA FUSIONADA, MODULADORES MGLUR5; COMPOSICION Y COMBINACION FARMACEUTICA QUE LOS COMPRENDE, UTILES EN EL TRATAMIENTO DE SINDROME X FRAGIL, PARKINSON, REFLUJO, ENTRE OTRAS.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充